In the literature, cases of blastomycosis in Canada have been documented in provinces bordering the Great Lakes, including Ontario and Quebec, as well as Manitoba. This is the first study to our knowledge reporting cases of mycosis seen in southern Saskatchewan suggesting a broader area of endemicity. We searched the Regina Qu'Appelle Health Region (RQHR) Microbiology Laboratory for all culture-confirmed cases of Blastomyces from January 2000 to December 2015 and identified 15 cases. Thirteen cases were reviewed, identifying common presenting symptoms, misdiagnosis, comorbidities, travel history, time from presentation to diagnosis, diagnostic specimen, treatment, and clinical outcome. Nine patients had no travel to areas known to be endemic to environmental blastomycosis. Eight patients presented with respiratory symptoms, four with skin lesions, four with constitutional symptoms, and one presented with chest pain after a fall. Initial misdiagnosis occurred in nine (69%) of the 13 cases, and all six patients that died of the disease were misdiagnosed. These six patients (46%) were acutely ill with refractory disseminated disease, leading to respiratory failure. It is probable that Blastomyces is present as an endemic fungus in the soil of southern Saskatchewan. Possibly due to a lack of awareness of this pathogen in the area, initial misdiagnoses were common and likely contributed to significant morbidity and mortality.
Introduction
Blastomycosis is a systemic fungal disease caused by the dimorphic fungus Blastomyces dermatitidis and Blastomyces glchristii. 1 A third species of Blastomyces was recently identified, Blastomyces percusus. 2 Infection occurs by inhalation of conidia produced by the environmental mould form, which then transforms into yeast in the body. 3 The respiratory tract is the primary portal of entry with clinical presentations ranging from asymptomatic to severe disseminated infection. In the United States, the fungus mainly lives in the soils of midwestern, south central, and southeastern states, particularly in areas surrounding the Ohio and Mississippi River valleys, the Great Lakes, and the Saint Lawrence River. 4, 5 The fungus is also endemic to areas in Canada, with cases documented in provinces bordering the Great Lakes, including Quebec, Ontario, and Manitoba. [6] [7] [8] Patients most commonly present with symptoms resembling an acute bacterial pneumonia (e.g., fever, chills, productive cough, and pleuritic chest pain) and a mass-like infiltrate on chest radiograph. Other clinical presentations include an influenza-like illness (e.g., fever, chills, arthralgias, headache, and a nonproductive cough) or a chronic illness resembling tuberculosis or lung cancer (e.g., fever, weight loss, night sweats, and productive cough). 9 The majority of patients with blastomycosis, whether symptomatic or not, have an alveolar or mass-like infiltrate on chest radiography. 9 Dissemination to other organs occurs in 25-40% of symptomatic individuals, occurring concurrently or subsequently to respiratory disease. 10, 11 Skin lesions are the most common extrapulmonary manifestation occurring in 40-80% of patients with disseminated diesase. 12 There are reports of transmission of blastomycosis after a bite wound from a pet; however, the vast majority of cutaneous lesions result from hematogenous spread not direct inoculation. 13 The early lesion is a papule or nodule, which may ulcerate and discharge pus. With time, this enlarges to form a verrucous and/or hyperkeratotic plaque with sharply demarcated borders. Multiple polymorphous skin lesions are found in disseminated infection and may include subcutaneous nodules, pustules, and draining sinuses. Oral lesions are uncommon. Skin lesions are often misdiagnosed as basal cell or squamous cell carcinoma, pyoderma gangrenosum, or keratoacanthoma. 9, 14 Fungal culture or direct visualization of characteristic broad-based, budding, thick-walled yeast is diagnostic of blastomycosis. 10 If left untreated, further dissemination of disease may occur, in some cases leading to diffuse pulmonary infiltrates and acute respiratory distress syndrome (ARDS). [15] [16] [17] In this study, we review 13 cases of human blastomycosis infection in southern Saskatchewan from 2000 to 2015. We examine and compare patient demographics, travel history, comorbidities, presenting symptoms, cutaneous manifestations, initial diagnoses, outcomes, and duration of treatment.
Methods
We searched the Regina Qu'Appelle Health Region (RQHR) Microbiology Laboratory for all culture- (Fig. 1) . 18 Charts were reviewed using our electronic health records service (Sunrise Clinical Manager), diagnostic laboratory reports, and health service provider notes. Information was extracted regarding: common presenting symptoms, misdiagnosis, comorbidities, travel history, time from presentation to diagnosis, diagnostic specimen, treatment, and clinical outcome.
Results
Our study identified 15 cases of human culture-confirmed Blastomyces infection diagnosed from January 2000 to December 2015. Two of 15 culture confirmed cases were not available for review as their charts were outside of the RQHR region and access was restricted. Eleven cases (85%) were male, and two (15%) were female, age ranged from 12 to 70 years old, with a mean age of 44 years (Table 1 ). All patients included in the study lived in Saskatchewan at the time of diagnosis. Nine (69%) had no travel history to regions known to have endemic environmental blastomycosis. In the remainder of patients travel history was not documented. One patient had emigrated from Egypt (8 years prior to presentation) and another from China (10 years prior to presentation). Two patients had documented exposure to local wet working environments within Saskatchewan: an electrician working in a basement contaminated with environmental mold, and a volunteer providing flood relief in a rural area. The source of culture confirmation varied depending on the presenting complaint and findings on imaging. Specimens were obtained from the lungs (bronchial washings, bronchoscopy brushings/biopsy, pleural fluid, and sputum) in nine cases, skin (biopsy) in four cases, an internal mass (splenic and chest wall fluid aspirates) in one case, and the last was confirmed on autopsy (culture confirmed disseminated blastomycosis of the lungs, heart, spleen, liver, adrenal glands, thyroid glands, and bilateral kidneys).
The majority of patients in our study presented with respiratory symptoms. Eight patients (62%) presented with symptoms resembling a bacterial pneumonia (productive/nonproductive cough, dyspnea, chest pain/discomfort). Of these patients six also had influenzalike symptoms (e.g., fever, chills, nausea, vomiting, myalgias, and/or arthralgias), and four had constitutional symptoms (e.g., weight loss, fever, chills, night sweats) ( Table 2) . One patient presented with nausea, vomiting, and recurrent fever/chills with no respiratory complaints; however, chest radiograph revealed a mass like infiltrate. Finally, one patient presented with chest pain after a fall, and a cavitating lesion was found incidentally in the right upper lobe.
The second most common presenting complaint was cutaneous lesions. Three patients (23%) presented with skin lesions and no systemic symptoms (cases 7, 10, 13). Skin manifestations were diverse and included a nonhealing ulceration of the ear, fluctuant subcutaneous nodules that broke and drained fluid to become nonhealing ulcerations, a necrotizing genital lesion, and a hyperkeratotic cratered lesion resembling a keratoacanthoma ( Table 2 ). The patient with fluctuant subcutaneous nodules (case 1) actually presented with pleuritic chest pain due to a chest wall mass. The lesions were not biopsied initially; instead aspirates of the chest wall mass were sent for culture once surgery could be arranged a month later, confirming infection.
Misdiagnosis was common to all but four cases (69%). Eight patients (62%) were diagnosed with pneumonia and treated with antimicrobial with or without corticosteroids prior to fungal culture being considered. The patient with a necrotizing genital lesion (case 13) initially presented to dermatology and was treated with high dose prednisone for a course of 3 months. A couple months later this gentleman was brought into hospital with increasing shortness of breath and was then diagnosed with disseminated blastomycosis. Another was treated for possible fulminant sarcoidosis (in addition to pneumonia) with corticosteroids. One patient's skin lesion resembled a keratoacanthoma (case 7), but the lesion was biopsied and left untreated until the results were obtained. Time from presentation to confirmed diagnosis ranged from 2 weeks to 16 weeks with a mean of 9.5 weeks. Of the nine patients misdiagnosed, six (67%) succumbed to the infection, and all patients that died of the disease were initially misdiagnosed.
Comorbidities in our patient population included: limb girdle muscular dystrophy, scleroderma, Crohn's disease, sarcoidosis, chronic lymphocytic leukemia, hepatitis C, asthma, coronary artery disease, diabetes mellitus, GERD, and alcohol use disorder (Table 1) . Three patients were current smokers. Of the eight patients with chronic comorbidities, four developed disseminated disease that resulted in death. Two patients in the study had no comorbid conditions and were well prior to infection (cases 1, 7). Two patients were on immunosuppressive therapy at the time of diagnosis (cases 6, 10) due to autoimmune comorbidities (scleroderma and Crohn's disease), both were treated successfully with complete resolution of symptoms. Six patients (46%) (all initially misdiagnosed) were acutely ill with disseminated disease and were treated with IV amphotericin B. All six of these patients were refractory to therapy, decompensated, and died in hospital. Five of the six fatalities were a result of acute respiratory distress syndrome (ARDS) (cases 2-5, 11-12). Thus, incidence of ARDS complicated deaths was 38% in our study. The patient mentioned previously (case 13), treated with high dose prednisone, unfortunately decompensated in hospital due to disseminated blastomycosis, and died of renal failure and severe gastrointestinal hemorrhage. Seven patients (54%) were managed in an outpatient setting and treated with azole antifungals (itraconazole, fluconazole, voriconazole) for 6 to 12 months (mean of 7.6 months). Six had complete resolution of symptoms, and one patient is currently being treated (case 1). One patient (case 10) with limited cutaneous disease was placed on itraconazole but developed biopsy confirmed recurrent lesions on the lower limbs. The patient was switched to voriconazole, with complete resolution of cutaneous lesions. Another patient with respiratory disease was treated for a total of 19 months of itraconazole/fluconazole with complete resolution of symptoms (case 9). The patient was stable clinically until a decade later when he presented to hospital with hemoptysis and worsening bilateral pulmonary infiltrates on CT scan. He was treated with itraconazole on a presumptive diagnosis of recurrent pulmonary blastomycosis. At 1 month follow-up, he was clinically doing very well with dramatic improvement in respiratory symptoms. There was no evidence of recurrence at 12 months follow-up.
Discussion
Blastomycosis is a systemic fungal disease caused by the dimorphic fungi Blastomyces. This study summarizes cases of human Blastomyces infection occurring in Regina Qu'Appelle Health Region Saskatchewan over a 16-year period, from 2000 to 2015 and builds on disease characteristics and epidemiology previously established within Canada.
The ecology of Blastomyces is incompletely defined and has been primarily based on outbreak investigations in which blastomycosis was cultured from the soil in association with human disease as well as isolated from the soil in absence out outbreak. 19, 20 The fungus is endemic to the Ohio and Mississippi River basins in the United States. 4, 5 In Canada, it is endemic to provinces bordering the Great Lakes, and the Saint Lawrence Riverway including Ontario, Quebec and Manitoba. [6] [7] [8] Case series have been performed in all three of the aforementioned provinces. Most of these areas border large bodies of water, which maintain moderate seasonal temperatures and a humid environment. This supports the idea that Blastomyces' ecological niche is moist soil near waterways. 10, 21 This case series is the first to our knowledge that documents cases of human blastomycosis in Saskatchewan, many of whom had no history of travel to known endemic areas. The environment of the central prairies is dry with well-drained soil and extremes of temperature. This could suggest that Blastomyces is able to withstand the extremes of this environment in its spore phase and aerosolize from the soil when it is disturbed. A retrospective study documented 142 cases of canine and feline blastomycosis originating from Saskatchewan and Manitoba in 2001-2010. 22 Cases were primarily from Regina, Moose Jaw, Swift Current, and Winnipeg, and the vast majority were canine (137 of 142). In our study, at least nine of the 13 cases reviewed had no travel history to areas endemic to blastomycosis. Taken together these findings suggest that Blastomyces is endemic to the soil of Southern Saskatchewan and that infection should be suspected in patients living in this region with compatible clinical presentations. Misdiagnosis is common in cases of blastomycosis. 9, [23] [24] [25] The majority of adult patients with clinical symptoms will present with an acute or chronic pneumonia, but up to 50% are asymptomatic with disease detected only as an incidental finding on chest radiograph. [26] [27] [28] In our cohort, eight patients (62%) were clinically diagnosed with pneumonia and treated with antimicrobials prior to fungal culture being considered. All six patients (46%) that died of the infection presented similarly with dyspnea, cough, and or production of sputum, fever, fatigue, and/or weight loss. Time from presentation to diagnosis varied from weeks to months depending on the acuity of illness and response to antimicrobial therapy. These six patients eventually decompensated in hospital with multiorgan and/or respiratory failure necessitating ventilation. They were managed aggressively with IV amphotericin once a diagnosis was made but unfortunately sustained numerous complications and died in hospital.
Overall mortality for all presentations of blastomycosis has been reported between 7 and 21%. [29] [30] [31] [32] Acute respiratory distress syndrome (ARDS) may complicate up to 15% of cases with studies citing mortality rates between 50 and 89%. [33] [34] [35] Overall mortality in our study was 46%, with 83% of deaths attributed to ARDS (overall incidence of 38%). These values are high compared to previous studies, which is likely due to lack of awareness and subsequent delayed or missed diagnosis. In addition, it is possible that less severe cases were treated without culture confirmation and thus not included in this study.
The skin is the second most common organ involved, often occurring concurrently with respiratory disease. 12, 14 Morphology is variable with the two main types documented being verrucous and ulcerative lesions although lesions may also appear as nodules, plaques and draining sinuses. 14 The ulcerations arise from subcutaneous abscesses that spontaneously drain. Subcutaneous abscesses can also be detected on physical exam without obvious cutaneous breakdown. Therefore, biopsy is essential as no clinical or imaging abnormality is diagnostic of blastomycosis. Fortunately, since the cutaneous form of the infection is visible to the eye, misdiagnosis is less common and time from presentation to diagnosis is typically reduced.
36
Of the four patients presenting with cutaneous lesions in our study, one was misdiagnosed and treated inappropriately (with high dose prednisone) without biopsy. Unfortunately, this misdiagnosis allowed for dissemination of infection ultimately leading to multi-organ failure and death.
To avoid misdiagnoses of blastomycosis in the future, clinicians should have a high suspicion in patients presenting with pneumonia unresponsive to antimicrobials, pneumonia coupled with skin lesions, or ARDS in a person who lives in or has visited an endemic area. Physicians should take a thorough travel and environmental exposure history and enquire about any pets that have been diagnosed with blastomycosis. If blastomycosis is suspected, it is essential that physicians request specific fungal stains and cultures, as it will not be detected on gram stain. Nonculture diagnostics (e.g., serum or urine Blastomyces antigens) have a high specificity (93% overall) and can be useful if available, although specificity is modest (79% overall) due to cross-reactive antigens. 19 If lesions are present, cutaneous biopsies should be performed in addition to culture from other body surfaces to aid in diagnosis and determine extent of disease. If blastomycosis is suspected, it is important to obtain cultures hastily as delays may allow for further dissemination to occur causing significant morbidity and mortality. There were several limitations in our study. First, we were not able to identify and review all cases of blastomycosis in southern Saskatchewan. Blastomycosis is not a reportable disease in Saskatchewan, so there may be cases diagnosed by histology alone or for whom empiric antifungal treatment was prescribed without culture confirmation. 37 Furthermore, a significant proportion of infections are asymptomatic and go undiagnosed. Autopsies are typically reserved for cases where the cause of death is unclear; thus, cases of blastomycosis where the cause of death was attributed to a bacterial pneumonia would likely also be missed. Data from Regina Qu'Appelle health Region were only considered, and it is very likely that the incidence would increase if data from all health regions in Saskatchewan were included. In order to obtain accurate population-level data, implementation of a mandatory reporting process is likely necessary. Due to the limitations outlined above, we are unable to establish the incidence of blastomycosis infection in the region. Reported incidence of the disease varies depending on the area but is estimated at 0.5 per 100 000, with occasional local areas attaining as high as 12 per 100 000. [38] [39] [40] Canadian estimates are slightly lower with an overall incidence of 0.3 cases per 100 000, 2.44 cases per 100 000 in Northern Ontario, and 0.62 cases per 100 000 in Manitoba. 6, 11 Interestingly, the Kenora region of Ontario has cited rates as high as 117 per 100 000 with aboriginal reserve communities experiencing 404.9 per 100 000. 40 Our study is retrospective and as such we relied on paper charts and health service provider notes to obtain data. In some cases, information was missing, such as a documented travel history, timeline from presentation to diagnosis or treatment, follow-up care, and long-term outcome. We are unable to definitively rule out acquisition of infection from traditionally endemic areas in four of the 13 patients, due to travel history being undocumented. Follow-up care was not fully documented in some cases, and in three cases, the patient was lost in follow-up.
Due to the small sample size in this study, a statistical analysis was not performed, and conclusions regarding risk factors for infection or epidemiologic trends in our patient population were not feasible. However, based on previous publications, most cases occur in middle-aged adults, but all age groups may be infected including infants and the elderly. 41 Sex has been inconsistently linked with blastomycosis infection, and male predominance cited in some studies may be due to participation in activities associated with exposure such as fishing, hiking, forestry, and so forth. 6, 11, 41 Racial distribution in Canada has not been firmly established, although studies in Manitoba have found a higher incidence of disease in aboriginal peoples. 13 Further studies are required to characterize the impact of Blastomyces on those residing in Saskatchewan. It is probable that Blastomyces is present as an endemic fungus in the soil of southern Saskatchewan. The previously recognized geographic distribution of Blastomyces needs to be reconsidered, and its accepted ecological niche potentially broadened. Furthermore, there may be implications for other prairie provinces/states, which may also be unrecognized endemic regions. Although uncommon, the virulence of Blastomyces infection should not be underestimated. Early diagnosis requires a high degree of clinical suspicion but is critical in preventing widespread dissemination of disease. It is likely that lack of awareness of this pathogen in the area contributed to initial misdiagnoses and delays in treatment. Awareness of locally acquired infections will raise diagnostic suspicion and help prevent significant delays in appropriate treatment, preventing significant morbidity and mortality.
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